Statistics for Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).

Total visits

views
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). 369

Total visits per month

views
October 2023 1
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0

File Visits

views
283537000011.pdf 373

Top country views

views
United States 52
United Kingdom 51
China 41
Germany 30
Canada 20
France 16
Russia 16
South Korea 7
Netherlands 6
Portugal 4
Ukraine 3
Greece 2
Singapore 2
South Africa 2
Austria 1
Belgium 1
Denmark 1
Hong Kong SAR China 1
Hungary 1
India 1
Iran 1
Poland 1
Taiwan 1

Top city views

views
Alexandria 28
Beijing 27
Göttingen 10
Omemee 10
Sainte-thérèse 10
Kiez 8
Woodbridge 5
Dallas 4
Lisbon 4
Seattle 4
Cupertino 3
Issaquah 3
Athens 2
Brooklyn 2
Changi 2
Durham 2
Illkirch-graffenstaden 2
Saint Petersburg 2
Schenectady 2
Seoul 2
Shenzhen 2
Arlington 1
Atlanta 1
Bangalore 1
Berlin 1
Birmingham 1
Bronx 1
Cape Town 1
Central District 1
Chicago 1
Chongqing 1
Copenhagen 1
Farmington 1
Frankfurt Am Main 1
Franklin Park 1
Gadsden 1
Hamden 1
Herbais 1
High Point 1
Johannesburg 1
Kirkland 1
Leiden 1
London 1
Mountain View 1
Munich 1
New York 1
Old Bridge 1
Overland Park 1
Plainsboro 1
Podolsk 1
Polska 1
Shenyang 1
Silver Spring 1
Somerville 1
Stillwater 1
Suzhou 1
York 1
Yulee 1